Business Industry Analysis News

Nucleic Acid Testing Market Research Report by IMARC 2020-2025

According to the IMARC Group Nucleic acid testing (NAT) stands for a molecular method used to screen viruses, bacteria or pathogenic nucleic acid in the patient’s blood, tissue, or urine. It is used for forensic examination and diagnosis of transfusion-borne infections, genetic disorders, and cancer. NAT includes sample pooling by nucleic acid (NA) extraction, target NA amplification, and target amplicon NA detection. Furthermore, the testing process also utilizes several kits and consumables for polymerase chain reaction (PCR), strand displacement amplification (SDA), transcription-mediated amplification (TMA), ligase chain reaction (LCR), and NA sequence-based amplification (NASBA) processes. NAT is widely adopted to classify illnesses that present no visible symptoms and to correct false reactive interpretations.

Request For a Sample Report:

The growing prevalence of infectious bacterial and viral diseases worldwide is one of the main factors augmenting the demand for NAT. In addition to this, the rising demand for advanced diagnostic systems is also catalyzing the market growth. Furthermore, numerous technological advancements have led to the development of novel biological diagnostic techniques, including signal and probe amplification systems, thereby propelling the global market. Extensive R&D activities in the medical field and several improvements in healthcare infrastructures are further expected to drive the market for NAT in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleic acid testing market report, along with forecasts for growth at the global, regional and country-level from 2020-2025. Our report has categorized the market based on region, product type, technology and end user.

Breakup by Product Type:

  • Instruments
  • Reagents and Consumables

Breakup by Technology:

  • TMA- Transcription-mediated Amplification
  • PCR- Polymerase Chain Reaction
  • LCR- Ligase Chain Reaction
  • SDA- Strand Displacement Amplification
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Pathology Laboratories
  • Research Institutes
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Explore Full Table of Contenet:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, Siemens Healthcare, Tecan Group AG and Thermo Fisher Scientific Inc.

Browse Related Report

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal